Effect of 8 Weeks Aerobic Training and Saffron Supplementation on Inflammation and Metabolism in Middle-Aged Obese Women with Type 2 Diabetes Mellitus
Overview
Authors
Affiliations
Background: This study aimed to investigate the effects of 8-week aerobic training (AT) and saffron supplementation on inflammation and metabolism in middle-aged obese women with type 2 diabetes mellitus (T2DM). Methods: Thirty-two obese women with T2DM were randomly divided into four groups (n = 8 in all groups): saffron + training (ST), placebo + training (PT), saffron supplementation (SS), and placebo (P). The ST and PT groups performed eight weeks of aerobic training (AT) (three sessions/week at 60−75% HRmax). A daily dose of 400 mg saffron powder was consumed by the ST and SS groups for 8 weeks. Blood samples were taken after 12 h of fasting, 48 h before the first AT session, 48 h and two weeks after the last AT session. Results: AT, saffron supplementation, and their combination affected body mass index (BMI), homeostatic model assessment for insulin resistance (HOMA-IR), and serum levels of insulin, adiponectin, interleukin-6 (IL-6), high-density lipoprotein cholesterol (HDL-C), cholesterol, and triglyceride (TG) (p < 0.05). However, body weight, body fat percentage, and serum levels of glucose, resistin, tumor necrosis factor-alpha (TNF-α), irisin, and low-density lipoprotein cholesterol (LDL-C) showed significant changes in the ST group only (p < 0.05). In addition, a significant difference was seen between all factors in post-training and follow-up in the ST group (p < 0.05). Conclusions: Saffron supplementation at a dose of 400 mg/day, when combined with AT, could improve inflammation, metabolism, glycemic status, and lipid profile in T2DM patients, and these changes are sustainable at up to 2 weeks of detraining.
Karim M, Pirzad S, Shirsalimi N, Hosseini M, Ebrahimi P, Khoshdooz S Diabetol Metab Syndr. 2024; 16(1):286.
PMID: 39593185 PMC: 11600967. DOI: 10.1186/s13098-024-01530-6.
Ouerghi N, Abassi W, Jebabli N, Feki M, Bouassida A, Weiss K BMC Res Notes. 2024; 17(1):246.
PMID: 39227898 PMC: 11373116. DOI: 10.1186/s13104-024-06918-1.
Khoramipour K, Rajizadeh M, Akbari Z, Arjmand M Heliyon. 2024; 10(15):e34917.
PMID: 39170342 PMC: 11336285. DOI: 10.1016/j.heliyon.2024.e34917.
Rajabi A, Akbar Nezhad Gharehlo A, Madadizadeh E, Basereh A, Khoramipoor K, Pirani H Eur J Sport Sci. 2024; 24(7):899-906.
PMID: 38874882 PMC: 11235750. DOI: 10.1002/ejsc.12125.
Khoramipour K, Rezaei M, Moslemizadeh A, Hosseini M, Ebrahimnezhad N, Bashiri H Behav Brain Funct. 2024; 20(1):9.
PMID: 38702776 PMC: 11067136. DOI: 10.1186/s12993-024-00235-0.